Dabigatran - A case history demonstrating the need for comprehensive approaches to optimize the use of new drugs

Rickard E. Malmström, Brian B. Godman*, Eduard Diogene, Christoph Baumgärte, Marion Bennie, Iain Bishop, Anna Brzezinska, Anna Bucsics, Stephen Campbell, Alessandra Ferrario, Alexander E. Finlayson, Jurij Fürst, Kristina Garuoliene, Miguel Gomes, Iñaki Gutiérrez-Ibarluzea, Alan Haycox, Krystyna Hviding, Harald Herholz, Mikael Hoffmann, Saira JanJan Jones, Roberta Joppi, Marija Kalaba, Christina Kvalheim, Ott Laius, Irene Langner, Julie Lonsdale, Sven Åke Lööv, Kamila Malinowska, Laura McCullagh, Ken Paterson, Vanda Markovic-Pekovic, Andrew Martin, Jutta Piessnegger, Gisbert Selke, Catherine Sermet, Steven Simoens, Cankat Tulunay, Dominik Tomek, Luka Voncina, Vera Vlahovic-Palcevski, Janet Wale, Michael Wilcock, Magdalena Wladysiuk, Menno Van Woerkom, Corrine Zara, Lars L. Gustafsson

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

70 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Dabigatran - A case history demonstrating the need for comprehensive approaches to optimize the use of new drugs'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science